Home › NDC Lookup › RxCUI directory › RxCUI 1806380

Once-Daily gabapentin 300 MG Oral Tablet — RxCUI 1806380

RxNorm drug concept · Semantic clinical drug
RxCUI 1806380 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 39 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1806380
Official nameOnce-Daily gabapentin 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped21
Package NDCs mapped39
Reported Medicaid activity (SDUD)6,688 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Gabapentin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Gabapentin is mainly used for two things: managing nerve pain that lingers after a shingles infection (called postherpetic neuralgia) in adults, and helping control partial onset s...
  • This is a really important question. Taking gabapentin together with opioids like morphine, hydrocodone, or oxycodone significantly raises the risk of serious breathing problems —...
  • Can I take gabapentin with my opioid pain medication?
  • The most common ones — especially in the first few weeks — are dizziness, drowsiness, and sometimes loss of balance or coordination. Swelling in the feet or hands is also fairly co...
📖 Read our full Gabapentin guide →

🕸️ Concept Web — How Once-Daily gabapentin 300 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Once-Daily gabapentin 300 MG Oral Tablet RxCUI 1806380

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Gabapentin 25480
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gralise 1087976
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Gabapentin Oral Tablet 378099
    • Gabapentin Oral Product 1156681
    • Gabapentin Pill 1156682
    • Gabapentin Oral Tablet [Gralise] 1115011
    • Gralise Oral Product 1172653
    • Gralise Pill 1172654
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

21 products · 39 package NDCs
39 package NDCs map to RxCUI 1806380 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0091-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-091-90) GABAPENTIN Camber Pharmaceuticals, Inc. 2024-02-26
31722-0092-90 90 TABLET, FILM COATED in 1 BOTTLE (31722-092-90) GABAPENTIN Camber Pharmaceuticals, Inc. 2024-02-26
42806-0656-09 90 TABLET in 1 BOTTLE (42806-656-09) Gabapentin Epic Pharma, LLC 2024-02-26
42806-0657-09 90 TABLET in 1 BOTTLE (42806-657-09) Gabapentin Epic Pharma, LLC 2024-02-26
50228-0523-05 500 TABLET in 1 BOTTLE (50228-523-05) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
50228-0523-30 30 TABLET in 1 BOTTLE (50228-523-30) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
50228-0523-90 90 TABLET in 1 BOTTLE (50228-523-90) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
50228-0524-05 500 TABLET in 1 BOTTLE (50228-524-05) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
50228-0524-30 30 TABLET in 1 BOTTLE (50228-524-30) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
50228-0524-90 90 TABLET in 1 BOTTLE (50228-524-90) gabapentin ScieGen Pharmaceuticals, Inc. 2025-09-20
52427-0803-90 90 TABLET, FILM COATED in 1 BOTTLE (52427-803-90) Gralise Almatica Pharma LLC 2020-10-01
52427-0804-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-804-60) Gralise Almatica Pharma LLC 2023-12-31
52427-0806-90 90 TABLET, FILM COATED in 1 BOTTLE (52427-806-90) Gralise Almatica Pharma LLC 2020-10-01
52427-0850-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-850-60) Gralise Almatica Pharma LLC 2023-12-31
52427-0890-60 60 TABLET, FILM COATED in 1 BOTTLE (52427-890-60) Gralise Almatica Pharma LLC 2023-12-31
68382-0355-01 100 TABLET in 1 BOTTLE (68382-355-01) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0355-14 60 TABLET in 1 BOTTLE (68382-355-14) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0356-01 100 TABLET in 1 BOTTLE (68382-356-01) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0356-14 60 TABLET in 1 BOTTLE (68382-356-14) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0357-01 100 TABLET in 1 BOTTLE (68382-357-01) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0357-14 60 TABLET in 1 BOTTLE (68382-357-14) gabapentin Zydus Pharmaceuticals USA Inc. 2025-09-18
68382-0607-05 500 TABLET in 1 BOTTLE (68382-607-05) gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
68382-0607-16 90 TABLET in 1 BOTTLE (68382-607-16) gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
68382-0607-77 10 BLISTER PACK in 1 CARTON (68382-607-77) / 10 TABLET in 1... gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
68382-0608-05 500 TABLET in 1 BOTTLE (68382-608-05) gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
68382-0608-16 90 TABLET in 1 BOTTLE (68382-608-16) gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
68382-0608-77 10 BLISTER PACK in 1 CARTON (68382-608-77) / 10 TABLET in 1... gabapentin Zydus Pharmaceuticals USA Inc. 2024-01-25
70771-1861-02 10 TABLET in 1 BLISTER PACK (70771-1861-2) gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1861-05 500 TABLET in 1 BOTTLE (70771-1861-5) gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1861-09 90 TABLET in 1 BOTTLE (70771-1861-9) gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1862-04 10 BLISTER PACK in 1 CARTON (70771-1862-4) / 10 TABLET in 1... gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1862-05 500 TABLET in 1 BOTTLE (70771-1862-5) gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1862-09 90 TABLET in 1 BOTTLE (70771-1862-9) gabapentin Zydus Lifesciences Limited 2024-01-25
70771-1916-01 100 TABLET in 1 BOTTLE (70771-1916-1) gabapentin Zydus Lifesciences Limited 2025-09-18
70771-1916-06 60 TABLET in 1 BOTTLE (70771-1916-6) gabapentin Zydus Lifesciences Limited 2025-09-18
70771-1917-01 100 TABLET in 1 BOTTLE (70771-1917-1) gabapentin Zydus Lifesciences Limited 2025-09-18
70771-1917-06 60 TABLET in 1 BOTTLE (70771-1917-6) gabapentin Zydus Lifesciences Limited 2025-09-18
70771-1918-01 100 TABLET in 1 BOTTLE (70771-1918-1) gabapentin Zydus Lifesciences Limited 2025-09-18
70771-1918-06 60 TABLET in 1 BOTTLE (70771-1918-6) gabapentin Zydus Lifesciences Limited 2025-09-18
Observed labelers: Zydus Lifesciences Limited (12) · Zydus Pharmaceuticals USA Inc. (12) · ScieGen Pharmaceuticals, Inc. (6) · Almatica Pharma LLC (5) · Camber Pharmaceuticals, Inc. (2) · Epic Pharma, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.